Pfizer doubles down on Syneos Health with new services pact

Pfizer has signed up for a new three-year deal, with the option for this to be extended to five years, with CRO Syneos Health.

The deal, financials of which were not disclosed, will see Syneos "deliver global product development solutions to support Pfizer's portfolio"—though, as usual with these deals, little extra details were provided.